Previous 10 | Next 10 |
home / stock / teli:cc / teli:cc news
Vancouver, British Columbia--(Newsfile Corp. - February 15, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (" Telescope " or the " Company "), a developer of enabling technologies for the global pharmaceutical and chemical industries, is pleased to welcome Henry Dubina as Chairm...
Vancouver, British Columbia--(Newsfile Corp. - February 5, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (" Telescope " or the " Company "), a developer of enabling technologies for the global pharmaceutical and chemical industries, announces it has signed a Distribution Agreem...
The Company exceeded its quarterly revenue and profit records in Q1, 2024 Vancouver, British Columbia--(Newsfile Corp. - January 30, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (" Telescope " or the " Company "), a developer of advanced technologies and services for the global...
A novel refinement process generates battery-quality lithium carbonate in a single step Vancouver, British Columbia--(Newsfile Corp. - January 23, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (" Telescope " or the " Company ") is a developer of advanced technologies and service...
Vancouver, British Columbia--(Newsfile Corp. - December 22, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (" Telescope " or the " Company "), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the...
Vancouver, British Columbia--(Newsfile Corp. - December 18, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (" Telescope " or the " Company "), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, announces it has filed a provisio...
The chem tech and precision filtration companies plan to develop a novel robotic sampling probe Vancouver, British Columbia--(Newsfile Corp. - October 30, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (" Telescope " or the " Company "), a leading developer of advanced tec...
Vancouver, British Columbia--(Newsfile Corp. - October 4, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (" Telescope " or the " Company "), a leading developer of advanced technologies for the global pharmaceutical and chemical industries, is excited to announce that its flagship...
Vancouver, British Columbia--(Newsfile Corp. - August 28, 2023) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (" Telescope " or the " Company "), a leading developer of advanced technologies and services for the global pharmaceutical and chemical industries, has been granted a Canadian...
Vancouver, British Columbia--(Newsfile Corp. - August 3, 2023) - Telescope Innovations Corp. (" Telescope " or the " Company ") (CSE: TELI), a chemical technology company, announces that it has granted a total of 800,000 incentive stock options (the " Options ") to certain directors of the Compan...
News, Short Squeeze, Breakout and More Instantly...
Telescope Innovations Corp. Company Name:
TELI:CC Stock Symbol:
CNQC Market:
Telescope Innovations Corp. Website:
Vancouver, British Columbia--(Newsfile Corp. - July 22, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (" Telescope " or the " Company "), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, has been awarded $400,273 in early-st...
Year-to-date revenues surpass entire fiscal year 2023 Vancouver, British Columbia--(Newsfile Corp. - July 11, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (" Telescope " or the " Company "), a developer of advanced technologies and services for the global pharmaceutical an...
Vancouver, British Columbia--(Newsfile Corp. - June 24, 2024) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (" Telescope " or the " Company "), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, has been accepted as a member of MaR...